Reported 1 day ago
UBS has reduced its price target for Colgate-Palmolive (CL) from $109 to $106 while maintaining a Buy rating, indicating continued confidence in the company's strong fundamentals despite challenges. The new target reflects a potential upside of about 22% from the current price of $86.80. Analysts observed consistent performance across Colgate's segments and expect margin recovery and disciplined brand investments to support earnings growth, while keeping an eye on future earnings updates for insights on cost trends and competitive dynamics.
Source: YAHOO